600645.SH
Vcanbio Cell & Gene Engineering Corp., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 17.61
+3.89%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 44.28x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 72.39x
- PEG TTM
- 52.21x
- Price / book
- 2.20x
- Price / sales
- 5.69x
- Price / cash flow
- 27.36x
Enterprise value
- Enterprise value
- CNY 6.6B
- EV / sales
- 4.64x
- EV / EBITDA
- 19.26x
- EV / EBIT
- 36.92x
- Market cap
- CNY 8.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026